skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Oxidative Stress and the Central Nervous System

The Journal of pharmacology and experimental therapeutics, 2017-01, Vol.360 (1), p.201-205 [Peer Reviewed Journal]

Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics. ;Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics 2017 ;ISSN: 0022-3565 ;EISSN: 1521-0103 ;DOI: 10.1124/jpet.116.237503 ;PMID: 27754930

Full text available

Citations Cited by
  • Title:
    Oxidative Stress and the Central Nervous System
  • Author: Salim, Samina
  • Subjects: Animals ; Brain - metabolism ; Central Nervous System - metabolism ; Humans ; Mental Disorders - metabolism ; Minireviews ; Neurodegenerative Diseases - metabolism ; Oxidative Stress
  • Is Part Of: The Journal of pharmacology and experimental therapeutics, 2017-01, Vol.360 (1), p.201-205
  • Description: Biochemical integrity of the brain is vital for normal functioning of the central nervous system (CNS). One of the factors contributing to cerebral biochemical impairment is a chemical process called oxidative stress. Oxidative stress occurs upon excessive free radical production resulting from an insufficiency of the counteracting antioxidant response system. The brain, with its high oxygen consumption and lipid-rich content, is highly susceptible to oxidative stress. Therefore, oxidative stress-induced damage to the brain has a strong potential to negatively impact normal CNS functions. Although oxidative stress has historically been considered to be involved mainly in neurodegenerative disorders such as Alzheimer disease, Huntington disease, and Parkinson disease, its involvement in neuropsychiatric disorders, including anxiety disorders and depression, is beginning to be recognized. This review is a discussion of the relevance of cerebral oxidative stress to impairment of emotional and mental well-being.
  • Publisher: United States: The American Society for Pharmacology and Experimental Therapeutics
  • Language: English
  • Identifier: ISSN: 0022-3565
    EISSN: 1521-0103
    DOI: 10.1124/jpet.116.237503
    PMID: 27754930
  • Source: MEDLINE
    Alma/SFX Local Collection

Searching Remote Databases, Please Wait